These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22397031)

  • 21. Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population.
    Komatsu M; Shibata N; Kuerban B; Ohnuma T; Baba H; Arai H
    Psychogeriatrics; 2011 Mar; 11(1):14-8. PubMed ID: 21447104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between genetic risk factors and markers for Alzheimer's disease pathology.
    Elias-Sonnenschein LS; Bertram L; Visser PJ
    Biomark Med; 2012 Aug; 6(4):477-95. PubMed ID: 22917148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue.
    Howlett DR; Hortobágyi T; Francis PT
    Brain Pathol; 2013 Nov; 23(6):623-32. PubMed ID: 23521156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's Disease-Current Status and Future Directions.
    Bhardwaj D; Mitra C; Narasimhulu CA; Riad A; Doomra M; Parthasarathy S
    J Med Food; 2017 Dec; 20(12):1141-1151. PubMed ID: 29131706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
    Zlokovic BV
    Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
    Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein J in Alzheimer's Disease: Shedding Light on Its Role with Cell Signaling Pathway Perspective and Possible Therapeutic Approaches.
    Moezzi SM; Mozafari N; Fazel-Hoseini SM; Nadimi-Parashkoohi S; Abbasi H; Ashrafi H; Azadi A
    ACS Chem Neurosci; 2020 Dec; 11(24):4060-4072. PubMed ID: 33251792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer's Disease.
    Chen P; Wang C; Ma X; Zhang Y; Liu Q; Qiu S; Liu Q; Tian J; Ni J
    PLoS One; 2013; 8(6):e66384. PubMed ID: 23805218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future horizons in Alzheimer's disease research.
    Wisniewski T; Drummond E
    Prog Mol Biol Transl Sci; 2019; 168():223-241. PubMed ID: 31699317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
    Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
    Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between multifunctional protein "clusterin" and Alzheimer disease.
    Choi-Miura NH; Oda T
    Neurobiol Aging; 1996; 17(5):717-22. PubMed ID: 8892344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?
    Del Valle E; Navarro A; Martínez-Pinilla E; Torices S; Tolivia J
    J Alzheimers Dis; 2016 May; 53(2):639-50. PubMed ID: 27197790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Amyloid Upregulates Intracellular Clusterin but not Secretory Clusterin in Primary Cultured Neurons and APP Mice.
    Wang P; Chen K; Gu Y; Guo Q; Hong Z; Zhao Q
    Curr Alzheimer Res; 2017; 14(11):1207-1214. PubMed ID: 28558636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ApoE facilitates the microglial response to amyloid plaque pathology.
    Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
    J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Clusterin as a Major ABri- and ADan-Binding Protein Using Affinity Chromatography.
    Rostagno A; Calero M; Ghiso J
    Methods Mol Biol; 2022; 2466():49-60. PubMed ID: 35585310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.